Has Jonathan Saluta, MD received payments from drug or device companies?

Yes. Drug and device makers reported $149,972 in general payments to Jonathan Saluta, MD across 329 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jonathan Saluta, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jonathan Saluta, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jonathan Saluta, MD

Surgery · Los Angeles, CANPI 1700998994

Payments from drug & device makers

$149,972in general payments, 2019–2025

Across 329 payments — averaging $455.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Heron Therapeutics, Inc.$57K
Maxx Orthopedics, Inc.$53K
Corentec America Inc$25K
Fidia Pharma USA Inc.$5K
Stryker$3K
Advanced Orthopaedic Solutions, Inc.$1K
plus $6K from 49 others

$11,700in research payments, 2019–2025

Across 3 payments — averaging $3900.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Maxx Orthopedics, Inc.$12K

What the payments were for

Consulting fees$29,84420%
Speaking & faculty fees$76,58851%
Travel & lodging$27,76019%
Food & beverage$15,78111%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Heron Therapeutics, Inc.	62	$56,974
Maxx Orthopedics, Inc.	14	$53,144
Corentec America Inc	39	$25,254
Fidia Pharma USA Inc.	39	$4,896
Stryker(2 entities)	52	$2,712
Advanced Orthopaedic Solutions, Inc.	2	$1,387
In2bones USA, LLC	4	$1,213
Medline Industries LP	5	$621
Smith+Nephew	6	$353
Maxx Health Inc	7	$343
Biom'up France SAS	4	$303
Medacta USA, Inc.	2	$288
Johnson & Johnson(3 entities)	13	$259
Globus Medical	8	$240
Integra Lifesciences Corporation	5	$237
Amgen(2 entities)	7	$140
Biom'up SA	1	$133
Pacira Pharmaceuticals Incorporated	2	$110
Biotissue Holdings Inc.	5	$106
Convatec Inc.	3	$87
Saxum Surgical, Inc.	2	$83
Heraeus Medical, LLC.	2	$74
Sunovion Pharmaceuticals Inc.	3	$66
Bioventus LLC	3	$65
Si-bone, Inc.	3	$58
Ferring Pharmaceuticals Inc.	4	$58
Baxter Healthcare	1	$55
Medtronic	2	$54
Linvatec Corporation	2	$50
Anika Therapeutics, Inc.	1	$47
Orthalign Inc	1	$45
Relievant Medsystems, Inc.	1	$42
Endo Pharmaceuticals Inc.	2	$37
Carbofix Orthopedics Inc	1	$36
Kerecis Limited	1	$36
Highridge Medical LLC	1	$29
Moximed, Inc	1	$24
Orthofix Medical, Inc.	1	$22
Orthogenrx Inc.	1	$22
Guard Medical Inc.	1	$20
Abbott	1	$20
Avanir Pharmaceuticals, Inc.	1	$19
Sanofi-aventis U.S. LLC	1	$19
Innovation Technologies Inc	1	$19
Pfizer	1	$18
Curonix LLC	1	$18
BD	1	$17
Bone Support Inc.	1	$16
Vertex	1	$16
Mallinckrodt Hospital Products Inc.	1	$16
Sun Pharmaceutical Industries Inc.	1	$16
Terumo BCT, Inc.	1	$14
Mallinckrodt Enterprises LLC	1	$14
Dynasplint Systems Inc.	1	$14
Paragon 28, Inc.	1	$12

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$149,972 in reported general payments places this provider in the 95th percentile of 2,363 surgery providers in California.

See all surgery providers in California →

Medicare billing

Part B allowed, 2024

$179,233

Medicare patients

268

Services billed

5,410

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	83	$669
Diclofenac Sodium	33	$633
Ibuprofen	58	$421
Acetaminophen-CodeineAcetaminophen With Codeine	21	$345
Cephalexin	25	$333
Meloxicam	85	$176
Tramadol Hcl	58	$174

Paid to pharmacies, not to this prescriber.

Other surgery in Los Angeles

John LiphamLos Angeles$991K
Caitlin HoughtonLos Angeles$643K
Nikolai BildzukewiczLos Angeles$348K
Miguel BurchLos Angeles$290K
Peyman BenharashLos Angeles$218K
Raul RosenthalLos Angeles$210K
Timothy DonahueLos Angeles$200K
Timothy ChuterSan Francisco$8.9M
Peter StockSan Francisco$6.5M
Santiago HorganSan Diego$2.8M

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →